Repeated renal infarction in native and transplanted kidneys due to left ventricular thrombus formation caused by antiphospholipid antibody syndrome

International Medical Case Reports Journal

Volumn 6, Issue 1, 2013, Pages 7-12

  Scully, Paul ^a   Leckstroem, Daniel C ^a   McGrath, Andrew ^a   Chambers, John ^a   Goldsmith, David J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antiphospholipid therapy; Emboli; Infarction; Kidney; Kidney transplant

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING PARAMETERS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DILUTE RUSSELL VIPER VENOM TIME; DISEASE SEVERITY; FLANK PAIN; HEART INFARCTION; HEART LEFT VENTRICLE ANEURYSM; HEART LEFT VENTRICULAR THROMBOSIS; HEMATURIA; HUMAN; INTRACARDIAC THROMBOSIS; KIDNEY ALLOGRAFT; KIDNEY CARCINOMA; KIDNEY FUNCTION; KIDNEY INFARCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; RECURRENT DISEASE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84872850191     PISSN: None     EISSN: 1179142X     Source Type: Journal    
DOI: 10.2147/IMCRJ.S39301     Document Type: Article

References (9)

1. Galliford J, Game DS. Modern renal transplantation: present challenges and future prospects. Postgrad Med J. 2009;85(1000):91-101.
2. Lai CK, Randhawa PS. Cholesterol embolization in renal allografts: clinicopathologic study of 12 cases. Am J Surg Pathol. 2007;31(4):536-545.
3. Canaud G, Bienaimé F, Noël LH, et al. Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies. Am J Transplant. 2010;10(9):2051-2060.
4. Keren A, Goldberg S, Gottlieb S, et al. Stern S. Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol. 1990;15(4):790-800.
5. Ileri M, Tandoǧan I, Koşar F, Yetkin E, Büyükaşik Y, Kütük E. Influence of thrombolytic therapy on the incidence of left ventricular thrombi after acute anterior myocardial infarction: role of successful reperfusion. Clin Cardiol. 1999;22(7):477-480.
6. Mahler M, Norman GL, Meroni PL, Khamashta M. Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome. Autoimmun Rev. 2012;12(2):313-317.
7. Pengo V, Denas G, Banzato A, et al. Secondary prevention in thrombotic antiphospholipid syndrome. Lupus. 2012;21(7):734-735.
8. Sciascia S, Murru V, Sanna G, Roccatello D, A Khamashta M, Laura Bertolaccini M. Clinical accuracy for diagnosis of Antiphospholipid Syndrome in SLE: evaluation of 23 possible combinations of antiphospholipid antibody specificities. J Thromb Haemost. 2012; doi: 10.1111/jth.12014. [Ebpub ahead of print.]
9. Serrano A, García F, Serrano M, et al. IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality. Kidney Int. 2012;81(12):1239-1244.